Pharmacia Corp

Underwriting Agreements Filter

EX-1.2
from 8-K ~20 pages Underwriting Agreement/Aces
12/34/56
EX-1.1
from 8-K ~20 pages Underwriting Agreement/Common Stock
12/34/56
EX-1
from S-3 ~20 pages Underwriting Agreement
12/34/56
EX-1
from 8-K ~50 pages Form of Distribution Agreement
12/34/56
EX-1
from SC 13D 1 page <page> 1 Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(f) Under the Securities Exchange Act of 1934, as Amended, Each of the Persons Named Below Agrees to the Joint Filing of a Statement on Schedule 13d (Including Amendments Thereto) With Respect to the Common Stock, Par Value $.01 Per Share, of Cytel Corporation, a Delaware Corporation, and Further Agrees That This Joint Filing Agreement Be Included as an Exhibit to Such Filings; Provided That, as Contemplated by Section 13d-1(f)(l)(ii), No Person Shall Be Responsible for the Completeness or Accuracy of the Information Concerning the Other Persons Making the Filing, Unless Such Person Knows or Has Reason to Believe That Such Information Is Inaccurate. This Joint Filing May Be Executed in Any Number of Counterparts, All of Which Together Shall Constitute One and the Same Instrument. G. D. Searle & Co. By: /S/ Richard U. De Schutter Title: Chief Executive Officer Monsanto Company By: /S/ Robert B. Hoffman Title: Chief Financial Officer
12/34/56
EX-1
from SC 13D/A 1 page Underwriting agreement
12/34/56
EX-1
from SC 13D/A ~10 pages Stock Purchase Agreement
12/34/56
EX-1
from SC 13D/A ~10 pages Stock Purchase Agreement
12/34/56
EX-1
from SC 13D ~50 pages Investment Agreement
12/34/56
EX-1
from S-3 ~20 pages Underwriting Agreement
12/34/56